The International Journal of Biochemistry & Cell Biology
Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects
Introduction
Airway hyperresponsiveness and bronchial inflammation are two hallmarks of asthma. More recently, an airway remodeling process involving altered extracellular matrix deposition has been recognized as a prominent feature of asthma [1], [2]. These changes in the extracellular matrix may contribute to abnormal airway function by altering airway mechanics and modulating inflammatory and structural cell function. In addition, airway fibrosis may lead to airway hyperresponsiveness. Indeed, both our group and others found a significant correlation between airway responsiveness and the degree of bronchial subepithelial fibrosis in asthmatic subjects [3], [4], [5].
In chronically inflamed airway tissues, activated fibroblasts are likely to contribute to the excessive deposition of different extracellular matrix components [6]. Functionally, asthmatic bronchial fibroblasts can be distinguished from their normal counterparts regarding contraction of collagen lattices [7], in vitro life-span [8], and expression of metalloproteinases [9], [10]. Moreover, cytokine production by bronchial fibroblasts could contribute to the asthmatic airway inflammation by regulating recruitment and activation of inflammatory cells [11], and inhibiting eosinophil apoptosis [12].
The deposition of collagen and fibronectin in the bronchial subepithelial region and its association with increased numbers of activated fibroblasts are well documented in asthma [13]. In addition to structural collagens and fibronectin, the airway walls contain proteoglycans, a family of ubiquitously distributed glycosylated proteins covalently linked with glycosaminoglycans. Proteoglycans determine tissue mechanical properties and are involved in many important biological aspects including cell–matrix and matrix–matrix interactions, cell proliferation, and binding and storage of growth factors [14].
To our knowledge, there are only three reports on the immunolocalization of proteoglycans in the asthmatic bronchial mucosa. As part of a review paper, Roberts mentioned the localization of versican, a large chondroitin sulphate proteoglycan, biglycan and decorin, two small chondroitin/dermatan sulphate proteoglycans, as well as hyaluronan, a glycosaminoglycan not attached to a core protein, in the bronchial mucosa of individuals who died from severe asthma [1]. The other reports are somehow more interesting because of the mildest form of asthma studied. Redington and colleagues showed that the overall pattern of decorin immunolocalization was similar in biopsy specimens from asthmatic and normal subjects [15]. Others found an increased staining for lumican, biglycan and versican, but not decorin, in the subepithelial layer of the airways in asthmatic subjects in comparison with that in normal subjects [16]. In this latter study, proteoglycan immunostaining was correlated with the extent of airway responsiveness in asthmatic subjects supporting the hypothesis that altered proteoglycan deposition may alter airway properties in asthma [17]. In addition, altered proteoglycan structure and production may have profound effects on the properties of the extracellular matrix, which can affect cell growth and migration as well as organization of matrix fibers [6].
An abnormal constitutive metabolism of proteoglycans characterizes fibroblasts from different fibrotic conditions, such as systemic or localized sclerosis [18], inflamed periodontal tissues [19], and nasal polyposis [20] to name a few. However, the production of proteoglycans by bronchial fibroblasts has not yet been investigated. In the present study, we measured the production of proteoglycans by bronchial fibroblasts from normal and asthmatic subjects and showed that there is a correlation between proteoglycan production by these cells and airway responsiveness of donor subjects.
Section snippets
Chemicals
Except when mentioned, all chemicals were obtained from sources previously listed [21], [22].
Bronchial fibroblast lines
Primary bronchial fibroblast lines from six mild asthmatic and four normal subjects were used in this study (Table 1). Asthmatic subjects had airway responsiveness (PC20 methacholine) ranging from 0.03 to 12.78 mg/ml and were all atopic using only an inhaled β2-agonist on demand. None have ever used inhaled or systemic corticosteroids. Normal subjects were non-atopic with no history of asthma or systemic
Production of hyaluronan and total proteoglycans
Fibroblast cultures secreted the main part of hyaluronan and total proteoglycans into the medium. Only 3.4%±0.7% of the former and 10.6%±1.5% (mean±standard error) of the latter was detected in the cell layer. Cells from subjects with the most hyperresponsive airways (low PC20 methacholine) produced up to four-fold more total proteoglycans than cells from subjects with less hyperresponsive and normoresponsive airways (high PC20) as reflected by the significant correlation, rs=−0.723 (P=0.030),
Discussion
The present study shows that serum-stimulated fibroblasts from subjects with the most hyperresponsive airways produced conspicuously more proteoglycans than cells from subjects with less hyperresponsive and normoresponsive airways. This translates into a significant negative correlation between PC20 methacholine and production of total proteoglycans, perlecan, small HSPGs and biglycan, but not decorin, while there was a tendency for hyaluronan and versican. Such alteration of proteoglycan
Acknowledgements
This work was supported in part by grants to G.M.T. from the Association pulmonaire du Québec, and to G.W.-T. from the Swedish Medical Research Council (11550), Heart and Lung Foundation, Swedish Cancer Fund, Swedish Society for Medical Research, JA Persson, G Nilsson, Greta and John Kock, A Österlund and Anna-Greta Crafoord Foundations, Riksföreningen mot Rheumatism, Gustaf V.s 80 Årsfond and the Medical Faculty, Lund University. J.C. and G.M.T. are scholars from Fonds de la recherche en santé
References (41)
- et al.
Tissue remodeling as a feature of persistent asthma
J. Allergy Clin. Immunol.
(2000) - et al.
Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine
Chest
(1997) - et al.
Airways remodeling is a distinctive feature of asthma and is related to severity of disease
Chest
(1997) - et al.
Decreased capacity of asthmatic bronchial fibroblasts to degrade collagen
Matrix Biol.
(2001) - et al.
The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TGF-β
Matrix
(1991) - et al.
Cytokine regulation of proteoglycan production in fibroblasts. Separate and synergistic effects
Matrix Biol.
(1997) - et al.
A simple, rapid, and sensitive DNA assay procedure
Anal. Biochem.
(1980) - et al.
Differential expression of mRNA for proteoglycans, collagens and transforming growth factor-β in the human cervix during pregnancy and involution
Biochim. Biophys. Acta
(1998) - et al.
Proteoglycans as modulators of growth factor activities
Cell
(1991) - et al.
Binding of fibromodulin and decorin to separate sites on fibrillar collagens
J. Biol. Chem.
(1993)
Interaction of heparin cofactor II with biglycan and decorin
J. Biol. Chem.
Selective expression and processing of biglycan during migration of bovine aortic endothelial cells. The role of endogenous basic fibroblast growth factor
J. Biol. Chem.
TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture
J. Mol. Cell. Cardiol.
Is asthma a fibrotic disease?
Chest
Expression of growth factors and remodelling of the airway wall in bronchial asthma
Thorax
Morphological and functional properties of bronchial cells isolated from normal and asthmatic subjects
Am. J. Respir. Cell Mol. Biol.
In vitro procollagen synthesis and proliferative phenotype of bronchial fibroblasts from normal and asthmatic subjects
Lab. Invest.
Bronchial myofibroblasts and tissue remodelling in asthma
Can. Respir. J.
Cytokine production by cell cultures from bronchial subepithelial myofibroblasts
J. Pathol.
Cited by (86)
The importance of lung microenvironment
2022, 3D Lung Models for Regenerating Lung TissueExtracellular Matrix: Matrix Proteoglycans
2021, Encyclopedia of Respiratory Medicine, Second EditionHyaluronan interactions with innate immunity in lung biology
2019, Matrix BiologyCitation Excerpt :In allergic asthma models and ex vivo examined cells from asthma patients, airway epithelia expressed versican, and may contribute to the subepithelial deposition of versican in asthmatic airways [187]. Undoubtedly, mesenchymal cells are major versican producers, and their versican production is further induced in disease; for example, increased versican production was described in fibroblasts from mild asthmatics [189], moderate to severe COPD [190] and transplanted lungs [191]. The mechanisms of this induction can be innate-immune triggered: versican production by mesenchymal cells was induced by innate immune activation through the TLR3 ligand polyI:C [192].
Interplay of extracellular matrix and leukocytes in lung inflammation
2017, Cellular ImmunologyCitation Excerpt :Hyaluronan has also been linked to localized collagen deposition in animal models of asthma [139]. Interestingly, fibroblasts from patients with airway hyper-responsiveness demonstrate greater overall ECM production than those from healthy individuals [140,141]. Collagens I and III, hyaluronan, and versican are, therefore, potentially important constituents of altered basement membranes and may be differentially regulated in asthma [128,132,142,143].
INOS affects matrix production in distal lung fibroblasts from patients with mild asthma
2015, Pulmonary Pharmacology and TherapeuticsCitation Excerpt :However, less is known regarding the role of more distally produced NO and the effect on remodelling processes and extracellular matrix (ECM) in the peripheral lung. As primary ECM producing cells, the lung fibroblasts are key players in remodelling processes by depositing ECM molecules such as proteoglycans [15,16]. Together these ECM molecules play a crucial role in maintaining tissue integrity and regulating tissue inflammation by storing cytokines and growth factors, which can be released under certain circumstances [17].
Hyaluronan and its heavy chain modification in asthma severity and experimental asthma exacerbation
2015, Journal of Biological Chemistry